Table 1 |
|||
|
Effects of dietary cholesterol on plasma lipids and inflammation markers |
|||
|
Con |
LC |
HC |
|
|
|
|||
|
Body weight (start) (g) |
20.3 ± 1.5 |
20.8 ± 1.5 |
20.6 ± 0.9 |
|
Body weight gain (g) |
0.4 ± 0.7 |
0.7 ± 0.8 |
0.6 ± 0.5 |
|
Food intake (g/day) |
2.6 ± 0.2 |
2.9 ± 0.3* |
2.5 ± 0.2† |
|
Plasma cholesterol (mM) |
5.9 ± 0.3 |
13.3 ± 1.9* |
17.9 ± 2.4*† |
|
Plasma triglyceride (mM) |
1.7 ± 0.4 |
2.3 ± 0.3 |
2.1 ± 0.7 |
|
Plasma E-selectin (μg/ml) |
44.3 ± 2.3 |
44.3 ± 6.3 |
55.1 ± 8.5*† |
|
Plasma SAA (μg/ml) |
2.8 ± 0.6 |
4.7 ± 1.7 |
8.3 ± 2.7*† |
|
Plasma ALAT (U/mL) |
48 ± 44 |
45 ± 22 |
75 ± 23 |
|
Plasma ASAT (U/mL) |
260 ± 123 |
237 ± 57 |
569 ± 221*† |
|
|
|||
|
Three groups of female E3L mice were fed either a cholesterol-free (Con) diet or the same diet supplemented with 0.25% (LC) or 1.0% (HC) w/w cholesterol. Listed are the average body weight at the start (t = 0) of the experimental period together with the body weight gain, the average daily food intake and the average plasma levels of cholesterol, triglycerides, E-selectin, serum amyloid A (SAA), alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT). All data are mean ± standard deviation. *P < 0.05 versus Con; †P < 0.05 versus LC (ANOVA, least significant difference post hoc test). |
|||
|
Kleemann et al. Genome Biology 2007 8:R200 doi:10.1186/gb-2007-8-9-r200 |
|||